Peripheral markers in obsessive-compulsive disorder: effect of treatments

Author： Marazziti D.   Pfanner C.   Rossi A.   Gemignani A.   Milanfranchi A.   Ravagli S.   Lensi P.   Presta S.   Cassano G.B.  

Publisher： Elsevier

ISSN： 0924-977X

Source： European Neuropsychopharmacology, Vol.5, Iss.3, 1995-09, pp. : 161-161

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Current and potential pharmacological treatments for obsessive-compulsive disorder

By Davidson Joyce   Bjorgvinsson Throstur  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 6, 2003-06 ,pp. : 993-1001

Informa Healthcare

Access to resources Recommend Favorite

Lymphocyte peripheral benzodiazepine receptor mRNA decreases in obsessive-compulsive disorder

By Rocca P.   Beoni A.M.   Eva C.   Ferrero P.   Maina G.   Bogetto F.   Ravizza L.  

European Neuropsychopharmacology, Vol. 10, Iss. 5, 2000-09 ,pp. : 337-340

Elsevier

Access to resources Recommend Favorite

Are there more effective drug treatments for obsessive compulsive disorder?

By Fineberg N.A.   Roberts A.   Montgomery S.A.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 208-208

Elsevier

Access to resources Recommend Favorite

Advances in the pharmacotherapy of obsessive-compulsive disorder

By Bisserbe J.C.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 260-260

Elsevier

Access to resources Recommend Favorite

Pathogenetic mechanism of obsessive-compulsive disorder

By Kafka J.   Paacute lovaacute E.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 370-371

Elsevier

Access to resources Recommend Favorite